Immunosuppressive drugs and their effects

The growing success of organ transplantation for the treatment of diabetes mellitus and end-stage renal, heart, lung, and liver disease is attributable, in part, to improvements in immunosuppressive regimens. This article reviews the immune response and the mechanism by which many immunosuppressants...

Full description

Saved in:
Bibliographic Details
Published inSeminars in respiratory infections Vol. 8; no. 3; p. 152
Main Authors Superdock, K R, Helderman, J H
Format Journal Article
LanguageEnglish
Published United States 01.09.1993
Subjects
Clinical Protocols
Cytokines - immunology
Graft Rejection - drug therapy
Graft Rejection - immunology
Graft Survival - immunology
Humans
Immunity, Cellular - immunology
Immunosuppressive Agents - immunology
Immunosuppressive Agents - therapeutic use
Inflammation
Lymphocyte Activation - immunology
T-Lymphocytes, Cytotoxic - immunology
Transplantation Immunology - drug effects
Transplantation Immunology - immunology
Online AccessGet more information

Cover

More Information
Summary:The growing success of organ transplantation for the treatment of diabetes mellitus and end-stage renal, heart, lung, and liver disease is attributable, in part, to improvements in immunosuppressive regimens. This article reviews the immune response and the mechanism by which many immunosuppressants exert their effects. Immunosuppressants discussed include azathioprine, glucocorticoids, cyclosporine A, cyclosporine G, FK506, rapamycin, mycophenolic acid, mycophenolate mofetil (RS-61443), mizoribine (bredinin), brequinar sodium, and deoxyspergualine. The efficacy and nonspecificity of these agents has led to significant side effects from their use, which can be predicted based on their mechanisms of action. The development and use of more specific immunosuppressants or the design of protocols, which would induce organ tolerance, may result in long-term organ survival without infectious or malignant complications.
ISSN:0882-0546